Please assess the completion status of the following clinical trial:

Trial Title: A Double-Blind Study on Adjunctive Use of PEMF in the Treatment of 5th Metatarsal Non-Union Fractures

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: QUADRUPLE
- Phase: None
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~1. Subject has been diagnosed with a 5th metatarsal delayed or non-union.~2. Subjects with duration of a 5th metatarsal fracture for a minimum of 3 months.~3. Male or female between ages of 18 and 75 years old, inclusive~Exclusion Criteria:~1. Subject has synovial pseudarthrosis.~2. Subject has a fracture gap of larger than 5mm as measured on CT Scan.~3. Subjects with conditions associated with elevated circulatory levels of inflammatory cytokines e.g., multiple trauma.~4. If female, subject is pregnant, plans on becoming pregnant during the duration of this clinical outcomes collection study or lactating.~5. Subject has an implanted unipolar pacemaker.~6. Subjects who have previous malignant or connective tissue disorder.~7. Subjects who use medication such as steroids or anticoagulants.~8. Subjects who have an underlying osseous infection (Osteomyelitis) and/or open wound.

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 75 Years
- Healthy Volunteers: f

Study Arms:
- EBI Bone Healing System + Surgery (Type: EXPERIMENTAL): Subject will be using the EBI Bone Healing System (active device) in conjunction with ORIF surgery of the nonunion site.
- Placebo Device + Surgery (Type: PLACEBO_COMPARATOR): Subject will be using a placebo device in conjunction with ORIF surgery of the nonunion site.

Based on this trial design, predict the completion outcome and termination type (if applicable).